Psoriatic arthritis

Patients should be aware that adherence with medication monitoring is vital, and be advised that metabolic and cardiovascular risk factors should be avoided or reduced.

The risks associated with nonsteroidal anti-inflammatory drugs (NSAIDs), conventional synthetic disease-modifying antirheumatic drugs (csDMARDS), targeted synthetic DMARDs (tsDMARDS), and biologic DMARDs (bDMARDS) should be emphasized. Patients should be counseled about adverse effects on gut, liver, and cardiovascular and renal toxicities.

Patients receiving immunosuppressant therapy should be taught how to recognize signs and symptoms of infection, and advised to seek medical attention if they become ill.

For continued support and information, patients can access various online resources. National Psoriasis Foundation Opens in new window